News Conference News ACC 2019 Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO Michael O'Riordan April 01, 2019
News Daily News FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies Michael O'Riordan December 06, 2018
News Conference News TCT 2018 RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation Todd Neale September 26, 2018
News Conference News TCT 2018 Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation Todd Neale September 25, 2018
News Conference News TCT 2018 Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO Todd Neale September 21, 2018
News Conference News EuroPCR 2018 Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension Michael O'Riordan May 23, 2018
News Conference News EuroPCR 2018 EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage Shelley Wood May 17, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2018 Caitlin E. Cox April 30, 2018
News Daily News Prominent Investigator Takes Post at Medtronic as Pivotal Renal Denervation Trial Is Announced Todd Neale April 12, 2018
News Industry News Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension April 09, 2018
News Conference News ESC 2017 Renal Denervation: Proof-of-Concept Study Gives Fresh Jolt to Fizzled Field Todd Neale August 28, 2017
News Opinion Editor's Corner ESC 2017 ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On Shelley Wood August 18, 2017
Presentation TCT 2016 TCT 762: Renal Denervation Treatment With the Symplicity Spyral Multielectrode Catheter: Six-Month Safety and Blood Pressure Outcomes From the Global SYMPLICITY Registry Presenter: Melvin D. Lobo, Adam Witkowski October 31, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: Medtronic GLOBAL SYMPLICITY SPYRAL HTN Trial Program Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, David E. Kandzari October 30, 2016
News Features Future of Renal Denervation May Hinge on a Handful of Small Studies Todd Neale February 14, 2016
News Industry News Medtronic Announces New SPYRAL HTN Global Clinical Trial Program for Renal Denervation April 01, 2015
Presentation TCT 2014 Renal Artery Denervation With A New Simultaneous Multielectrode Catheter For Treatment Of Resistant Hypertension: 12-Month Update From The SYMPLICITY Spyral First-In-Man Study Presenter: Robert Whitbourn September 16, 2014
Presentation TCT 2014 24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension ? First Results Fr___ Presenter: Alexander Plehn September 16, 2014
News Industry News Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension December 16, 2013
Presentation TCT 2013 Device and Clinical Trial Update: Symplicity and Spyral (Medtronic) Presenter: David Kandzari October 27, 2013